Phase 2 Recurrent Low Grade Glioma Clinical Trials

2 recruitingPhase 2

What is a Phase 2 trial?

Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.

Showing 1–2 of 2 trials

Recruiting

Phase 2

Dabrafenib and Trametinib for BRAF V600 Mutant Low-Grade Gliomas

BRAF V600 MutationLow-grade GliomaLow Grade Glioma of Brain+1 more

University of California, San Francisco96 enrolled5 locationsNCT07110246

Recruiting

Phase 1Phase 2

SJ901: Evaluation of Mirdametinib in Children, Adolescents, and Young Adults With Low-Grade Glioma

Low-grade GliomaRecurrent Low Grade GliomaProgressive Low-Grade Glioma

St. Jude Children's Research Hospital132 enrolled1 locationNCT04923126